
Proscia Partners with Nucleai to Enhance Precision Medicine with AI-Powered Pathology
PHILADELPHIA, PA, and CHICAGO, IL — Proscia®, a leading provider of digital and computational pathology solutions, has entered into a partnership with Nucleai, an AI-based predictive biomarker company. This collaboration …
Proscia Partners with Nucleai to Enhance Precision Medicine with AI-Powered Pathology Read More